Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Instituto do Cancer do Estado de São Paulo
Radboud University Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Taiwan University Hospital
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Stanford University
Grupo Espanol de Tumores Neuroendocrinos
M.D. Anderson Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
Hospices Civils de Lyon
University of Nebraska
M.D. Anderson Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
University Health Network, Toronto
University Health Network, Toronto
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Memorial Sloan Kettering Cancer Center
Exelixis
Sanofi
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fujian Medical University
University Medical Center Groningen
Stanford University
Hoffmann-La Roche
Mayo Clinic
Fujian Medical University
National Cancer Center, Korea
National Cancer Center, Korea
National Cancer Center, Korea
Nanjing First Hospital, Nanjing Medical University
M.D. Anderson Cancer Center
The First Affiliated Hospital of Xiamen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)